Amarin Corp Plc (AMRN)

[chantillylive]

JL... well written comments. Thank you as always.


Now, my reasoning regarding a possible BO in three (3) years or so...

The five stages in the product life cycle are product development, introduction, growth, maturity, and decline. AMRN is just now exiting the development stage. Some might say Vascepa is still developing and I would not argue with them. My Bottom Line (BL) is as products enter maturity, a buy out is a reasonable expectation. Say an Amazon.

One caveat with AMRN is when does it mature. Can/will it become the next aspirin, Xerox, Coke,...? Will it be dried and sprinkled onto my oatmeal? Into my Powerade? My favorite German wine?

BL: A merger with some yet unknown distributor must occur during the Maturity Phase. When/What that merger looks like years from now is obviously unknown. However, biotechs are neither marketing nor distribution centers.

Question: Is AMRN/Vascepa a once-in-a-lifetime investment/product?
I think not. The material question is: What is the next AMRN/Vascepa?